EMCDDA news

Green light for two-year work programme on bilateral cooperation with Georgia

A two-year work programme on bilateral cooperation with Georgia was agreed upon today at the first advisory committee meeting of the EMCDDA4Georgia project, hosted virtually by the agency. Launched on 3 May this year, the project aims to enhance national responses to drug-related health and security threats and focuses primarily on knowledge transfer and capacity-building in the areas of drug monitoring, reporting, prevention and treatment. 28.09.2021 
Čtěte více

Six steps to improve the quality of drug services and systems — EMCDDA launches new practical manual for decision-makers

Six steps to help improve the quality of drug services and systems in Europe are presented today in a new manual from the EU drugs agency (EMCDDA). Entitled Implementing quality standards for drug services and systems: a six-step guide to support quality assurance, the publication offers practical advice for professionals implementing quality assurance in the area of drug demand reduction. 27.09.2021 
Čtěte více

EMCDDA expert meeting on digital health innovation

Recent EMCDDA studies on the impact of COVID-19 containment measures on drug services in Europe highlighted the rapid and widespread adoption of telemedicine and online communication. In some countries, core drug treatment modalities moved online and virtual technologies were used to support more conventional treatment approaches. In line with these developments, the EMCDDA is hosting an expert meeting today dedicated to digital health innovation. 03.09.2021 
Čtěte více

Dne 2. července 2024 se centrum EMCDDA stalo Agenturou Evropské unie pro drogy (EUDA).
Web agentury: https://www.euda.europa.eu Informační stránka o novém mandátu centra EMCDDA (agentury EUDA) je na webu EUDA k dispozici i v češtině - OTEVŘÍT Změnily se i e-mailové adresy zaměstnanců agentury, jsou nyní ve formátu jmeno.prijmeni@euda.europa.eu.